Shingles vaccine linked to 24% lower dementia risk
A study involving over 500,000 older adults found that those who received the Shingrix shingles vaccine had a 24% lower risk of being diagnosed with dementia over four years. Researchers estimate this could prevent approximately one case of dementia for every 17 people vaccinated.
A study involving over 500,000 older adults found that those who received the Shingrix shingles vaccine had a 24% lower risk of being diagnosed with dementia over four years. Researchers estimate this could prevent approximately one case of dementia for every 17 people vaccinated.
Sources
- ScienceDaily — Shingles vaccine linked to 24% lower dementia risk
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。
VictoriaPark 纵深
AI analysisThis finding suggests a potential dual benefit of Shingrix, enhancing its value for older adults. However, further research is needed to confirm this link.
The shingles vaccine (Shingrix) may offer neuroprotective benefits beyond preventing shingles, potentially reducing the risk of dementia in older adults.
- Clinical trials specifically designed to test the relationship between shingles vaccination and dementia risk
- Longitudinal studies following vaccinated individuals over extended periods
VictoriaPark 独立分析，依据下列来源；这部分是推断，而非来源已经报道或交叉证实的事实。 Model: qwen2.5:7b-instruct